Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction

AIMS: An increasing proportion of patients with heart failure with reduced ejection fraction (HFrEF) have co‐morbidities. The effect of these co‐morbidities on modes of death and the effect of disease‐modifying agents in multi‐morbid patients is unknown. METHODS AND RESULTS: We performed a prospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Straw, Sam, McGinlay, Melanie, Relton, Samuel D., Koshy, Aaron O., Gierula, John, Paton, Maria F., Drozd, Michael, Lowry, Judith E, Cole, Charlotte, Cubbon, Richard M, Witte, Klaus K., Kearney, Mark T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754757/
https://www.ncbi.nlm.nih.gov/pubmed/32924331
http://dx.doi.org/10.1002/ehf2.12978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754757/
https://www.ncbi.nlm.nih.gov/pubmed/32924331
http://dx.doi.org/10.1002/ehf2.12978

Ejemplares similares